X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (75) 75
male (62) 62
middle aged (58) 58
female (55) 55
adult (47) 47
aged (45) 45
index medicus (44) 44
hematology (41) 41
aged, 80 and over (25) 25
chemistry (19) 19
metallurgy (19) 19
multiple myeloma (19) 19
oncology (19) 19
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
leukemia, lymphocytic, chronic, b-cell - drug therapy (15) 15
analysis (12) 12
apoptosis (12) 12
treatment outcome (12) 12
chemotherapy (11) 11
compositions based thereon (11) 11
disease (11) 11
leukemia (11) 11
organic macromolecular compounds (11) 11
their preparation or chemical working-up (11) 11
adolescent (10) 10
rituximab (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
cancer (9) 9
cells (9) 9
leukemia, lymphocytic, chronic, b-cell - pathology (9) 9
macromolecular compounds obtained otherwise than by reactionsonly involving unsaturated carbon-to-carbon bonds (9) 9
multiple myeloma - blood (9) 9
multiple myeloma - drug therapy (9) 9
peripheral vascular disease (9) 9
survival (9) 9
young adult (9) 9
acyclic or carbocyclic compounds (8) 8
case-control studies (8) 8
chronic lymphocytic leukaemia (8) 8
disease-free survival (8) 8
expression (8) 8
fludarabine (8) 8
multicenter (8) 8
organic chemistry (8) 8
recurrence (8) 8
therapy (8) 8
thrombosis (8) 8
chlorambucil (7) 7
chronic lymphocytic leukemia (7) 7
cladribine - administration & dosage (7) 7
hematology, oncology and palliative medicine (7) 7
leukemia, lymphocytic, chronic, b-cell - blood (7) 7
leukemia, myeloid, acute - mortality (7) 7
medical research (7) 7
prognosis (7) 7
agriculture (6) 6
animal husbandry (6) 6
biocides, e.g. as disinfectants, as pesticides, as herbicides (6) 6
biomarkers, tumor - blood (6) 6
cll (6) 6
cyclophosphamide (6) 6
cyclophosphamide - administration & dosage (6) 6
drug administration schedule (6) 6
fishing (6) 6
follow-up studies (6) 6
forestry (6) 6
human necessities (6) 6
hunting (6) 6
medical colleges (6) 6
neutropenia (6) 6
pest repellants or attractants (6) 6
plant growth regulators (6) 6
preservation of bodies of humans or animals or plants or partsthereof (6) 6
proteasome (6) 6
remission induction (6) 6
risk (6) 6
transplantation (6) 6
trapping (6) 6
trial (6) 6
vidarabine - analogs & derivatives (6) 6
acute myelogenous leukemia (5) 5
acute myeloid leukemia (5) 5
bortezomib (5) 5
care and treatment (5) 5
chronic lymphocytic-leukemia (5) 5
cladribine (5) 5
coagulation (5) 5
guidelines (5) 5
leukemia, lymphocytic, chronic, b-cell - mortality (5) 5
medicine (5) 5
medicine, experimental (5) 5
medicine, general & internal (5) 5
medicine, research & experimental (5) 5
ofatumumab (5) 5
patients (5) 5
plasma (5) 5
vidarabine - administration & dosage (5) 5
antibodies, monoclonal - administration & dosage (4) 4
antimitotic agents (4) 4
antineoplastic agents (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9980, pp. 1873 - 1883
Summary Background Treatment for patients with chronic lymphocytic leukaemia who are elderly or who have comorbidities is challenging because fludarabine-based... 
Internal Medicine | BENDAMUSTINE | 1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | CLL | CYCLOPHOSPHAMIDE | CHEMOIMMUNOTHERAPY | RITUXIMAB | MONOCLONAL-ANTIBODIES | ELDERLY-PATIENTS | FLUDARABINE | HUMAN CD20 | Age Distribution | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Chlorambucil - adverse effects | Prospective Studies | Chlorambucil - therapeutic use | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents, Alkylating - administration & dosage | Aged, 80 and over | Adult | Female | Chlorambucil - administration & dosage | Drug Administration Schedule | Kaplan-Meier Estimate | Treatment Outcome | Antineoplastic Agents, Alkylating - therapeutic use | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sex Distribution | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Antineoplastic Agents, Alkylating - adverse effects | Chlorambucil | Medical colleges | Hospitals | Comorbidity | United Kingdom | Product development | India | Medical research | Flow cytometry | Immunoglobulins | Medical imaging | Laboratories | Cytotoxicity | Infections | Ovarian cancer | Bone marrow | Drug dosages | Age | Binding sites | Geriatrics | Neutropenia
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 19, pp. 1759 - 1769
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2007, Volume 357, Issue 22, pp. 2237 - 2247
Journal Article
Folia Histochemica et Cytobiologica, ISSN 0239-8508, 2011, Volume 49, Issue 4, pp. 654 - 658
Mucins have been shown to be aberrantly overexpressed in various diseases including cystic fibrosis, asthma, and cancer. Recent studies have uncovered the... 
sMUC-1 | Multiple myeloma | multiple myeloma | BIOCHEMISTRY & MOLECULAR BIOLOGY | ANTIBODY | EPITHELIAL MUCIN | CORE PROTEIN | CELL BIOLOGY | BREAST-CANCER | DF3 ANTIGEN | PROGNOSTIC-SIGNIFICANCE | MUC-1 | CARCINOMA | EXPRESSION | T-CELLS | Disease-Free Survival | Multiple Myeloma - pathology | Humans | Middle Aged | Mucin-1 - blood | Adult | Female | Male | Aged | Disease Progression | Multiple Myeloma - blood
Journal Article
Journal Article
International Journal of Infectious Diseases, ISSN 1201-9712, 2017, Volume 61, Issue C, pp. 70 - 73
Journal Article
British Journal of Haematology, ISSN 0007-1048, 02/2017, Volume 176, Issue 4, pp. 618 - 628
Summary Otlertuzumab (TRU‐016) is a humanized anti‐CD37 protein therapeutic that triggers direct caspase‐independent apoptosis of malignant B cells and induces... 
CLL | otlertuzumab | bendamustine | ANTIBODIES | DIAGNOSIS | NON-HODGKINS-LYMPHOMAS | QUANTITATIVE FLOW-CYTOMETRY | II TRIAL | CHRONIC LYMPHOPROLIFERATIVE DISORDERS | FLUDARABINE | THERAPY | RITUXIMAB | B-CELL MALIGNANCIES | HEMATOLOGY | Bendamustine Hydrochloride - therapeutic use | Recurrence | Salvage Therapy - adverse effects | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Fever - chemically induced | Leukemia, Lymphocytic, Chronic, B-Cell - complications | Bendamustine Hydrochloride - administration & dosage | Aged, 80 and over | Adult | Female | Neutropenia - chemically induced | Antineoplastic Agents, Alkylating | Recombinant Fusion Proteins - administration & dosage | Drug Administration Schedule | Immunoglobulin G - therapeutic use | Immunoglobulin G - administration & dosage | Remission Induction | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Salvage Therapy - methods | Antimitotic agents | Medical research | Care and treatment | Relapse | Medicine, Experimental | B cells | Antineoplastic agents | Hyperthermia | Fever | Diseases | Chronic lymphatic leukemia | Toxicity | Leukemia | Caspase | Cytotoxicity | Patients | Incidence | Infusion | Lymphocytes B | Response rates | Neutropenia | Apoptosis | Antibody-dependent cell-mediated cytotoxicity | Research Paper | Haematological Malignancy
Journal Article
Blood Cells, Molecules and Diseases, ISSN 1079-9796, 07/2016, Volume 59, pp. 92 - 96
We aimed to analyse whether quantitative assessment of peripheral blood lymphocyte CD19 CD20 CD22 CD79a B cells, CD3 CD4 CD5 CD8 T cells and CD4 CD25 Foxp3high... 
T-cells | B-cells | Tregs | Diffuse large B-cell lymphoma | Apoptosis | RESPONSE CRITERIA | ADENOSINE | LYMPHOMA PATIENTS | MEDIATED APOPTOSIS | SUPPRESSION | SUPPORT | ROLES | REGULATORY T-CELLS | HEMATOLOGY | Lymphoma, Large B-Cell, Diffuse - diagnosis | Flow Cytometry - methods | Lymphocytes - pathology | Prognosis | Humans | Lymphocyte Count | Lymphocytes - cytology | T cells | Analysis | B cells
Journal Article